Literature DB >> 23858063

Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?

S Di Bella, F Taglietti, N Petrosillo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23858063      PMCID： PMC3719784          DOI： 10.1128/AAC.00828-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  Azithromycin and the risk of cardiovascular death.

Authors:  Wayne A Ray; Katherine T Murray; Kathi Hall; Patrick G Arbogast; C Michael Stein
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

2.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

Review 3.  The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-08       Impact factor: 3.869

4.  Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection.

Authors:  Kevin A Brown; Nagham Khanafer; Nick Daneman; David N Fisman
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

5.  The epidemiology of community-acquired Clostridium difficile infection: a population-based study.

Authors:  Sahil Khanna; Darrell S Pardi; Scott L Aronson; Patricia P Kammer; Robert Orenstein; Jennifer L St Sauver; W Scott Harmsen; Alan R Zinsmeister
Journal:  Am J Gastroenterol       Date:  2011-11-22       Impact factor: 10.864

6.  Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes.

Authors:  Núria Fernández-Sabé; Jordi Carratalà; Beatriz Rosón; Jordi Dorca; Ricard Verdaguer; Frederic Manresa; Francesc Gudiol
Journal:  Medicine (Baltimore)       Date:  2003-05       Impact factor: 1.889

Review 7.  Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network.

Authors:  Tobias Welte; Thomas Köhnlein
Journal:  Semin Respir Crit Care Med       Date:  2009-03-18       Impact factor: 3.119

8.  Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection.

Authors:  Sandra Dial; Abbas Kezouh; Andre Dascal; Alan Barkun; Samy Suissa
Journal:  CMAJ       Date:  2008-10-07       Impact factor: 8.262

9.  Does doxycycline protect against development of Clostridium difficile infection?

Authors:  Sarah B Doernberg; Lisa G Winston; Daniel H Deck; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2012-05-04       Impact factor: 9.079

10.  Community-associated Clostridium difficile infections, Monroe County, New York, USA.

Authors:  Ghinwa Dumyati; Vanessa Stevens; George E Hannett; Angela D Thompson; Cherie Long; Duncan Maccannell; Brandi Limbago
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883
  10 in total
  2 in total

1.  Reply to "Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?".

Authors:  Kevin A Brown; Nagham Khanafer; Nick Daneman; David N Fisman
Journal:  Antimicrob Agents Chemother       Date:  2013-08       Impact factor: 5.191

2.  Why Does Doxycycline Pose a Relatively Low Risk for Promotion of Clostridioides difficile Infection?

Authors:  Dongyan Xu; Thriveen S C Mana; Jennifer L Cadnum; Abhishek Deshpande; Faezeh Afsari; Naseer Sangwan; Curtis J Donskey
Journal:  Pathog Immun       Date:  2022-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.